Steven Bourgault - Publications

Chemistry Univ. of Quebec at Montreal 

27/47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wolwertz ML, Nguyen PT, Quittot N, Bourgault S. Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation. Biochimica Et Biophysica Acta. PMID 26802902 DOI: 10.1016/j.bbapap.2016.01.009  0.92
2015 Tchoumi Neree A, Nguyen PT, Bourgault S. Cell-Penetrating Ability of Peptide Hormones: Key Role of Glycosaminoglycans Clustering. International Journal of Molecular Sciences. 16: 27391-400. PMID 26580613 DOI: 10.3390/ijms161126025  0.92
2015 Nguyen PT, Andraka N, De Carufel CA, Bourgault S. Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis. Journal of Diabetes Research. 2015: 515307. PMID 26576436 DOI: 10.1155/2015/515307  0.92
2015 De Carufel CA, Quittot N, Nguyen PT, Bourgault S. Delineating the Role of Helical Intermediates in Natively Unfolded Polypeptide Amyloid Assembly and Cytotoxicity. Angewandte Chemie (International Ed. in English). PMID 26440575 DOI: 10.1002/anie.201507092  0.92
2015 Pratt J, Iddir M, Bourgault S, Annabi B. Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma. Molecular Carcinogenesis. PMID 25640948 DOI: 10.1002/mc.22264  0.92
2015 Chatenet D, Bourgault S, Fournier A. Design and application of light-activated probes for cellular signaling. Methods in Molecular Biology (Clifton, N.J.). 1234: 17-30. PMID 25304345 DOI: 10.1007/978-1-4939-1755-6_3  0.92
2014 Tchoumi Neree A, Nguyen PT, Chatenet D, Fournier A, Bourgault S. Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP. Febs Letters. 588: 4590-6. PMID 25447531 DOI: 10.1016/j.febslet.2014.10.029  0.92
2014 Hassanpour A, De Carufel CA, Bourgault S, Forgione P. Synthesis of 2,5-diaryl-substituted thiophenes as helical mimetics: towards the modulation of islet amyloid polypeptide (IAPP) amyloid fibril formation and cytotoxicity. Chemistry (Weinheim An Der Bergstrasse, Germany). 20: 2522-8. PMID 24488624 DOI: 10.1002/chem.201303928  0.92
2013 De Carufel CA, Nguyen PT, Sahnouni S, Bourgault S. New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity. Biopolymers. 100: 645-55. PMID 23526456 DOI: 10.1002/bip.22243  0.92
2011 Bourgault S, Choi S, Buxbaum JN, Kelly JW, Price JL, Reixach N. Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs. Biochemical and Biophysical Research Communications. 410: 707-13. PMID 21557933 DOI: 10.1016/j.bbrc.2011.04.133  0.92
2011 Bourgault S, Chatenet D, Wurtz O, Doan ND, Leprince J, Vaudry H, Fournier A, Vaudry D. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Current Pharmaceutical Design. 17: 1002-24. PMID 21524253 DOI: 10.2174/138161211795589337  0.92
2011 Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, Vaudry D. PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action. Peptides. 32: 1207-16. PMID 21514338 DOI: 10.1016/j.peptides.2011.04.003  0.92
2011 Solomon JP, Bourgault S, Powers ET, Kelly JW. Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension. Biochemistry. 50: 2486-98. PMID 21348501 DOI: 10.1021/bi101905n  0.92
2011 Bourgault S, Solomon JP, Reixach N, Kelly JW. Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion. Biochemistry. 50: 1001-15. PMID 21194234 DOI: 10.1021/bi101822y  0.92
2011 Dejda A, Bourgault S, Doan ND, Létourneau M, Couvineau A, Vaudry H, Vaudry D, Fournier A. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP. Biochimie. 93: 669-77. PMID 21185349 DOI: 10.1016/j.biochi.2010.12.010  0.92
2011 Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochemical Pharmacology. 81: 552-61. PMID 21114961 DOI: 10.1016/j.bcp.2010.11.015  0.92
2009 Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Current Medicinal Chemistry. 16: 4462-80. PMID 19835562 DOI: 10.2174/092986709789712899  0.92
2009 Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacological Reviews. 61: 283-357. PMID 19805477 DOI: 10.1124/pr.109.001370  0.92
2009 Bourgault S, Vaudry D, Ségalas-Milazzo I, Guilhaudis L, Couvineau A, Laburthe M, Vaudry H, Fournier A. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. Journal of Medicinal Chemistry. 52: 3308-16. PMID 19413310 DOI: 10.1021/jm900291j  0.92
2008 Dejda A, Jolivel V, Bourgault S, Seaborn T, Fournier A, Vaudry H, Vaudry D. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. Journal of Molecular Neuroscience : Mn. 36: 26-37. PMID 18506634 DOI: 10.1007/s12031-008-9087-1  0.92
2008 Bourgault S, Vaudry D, Guilhaudis L, Raoult E, Couvineau A, Laburthe M, Ségalas-Milazzo I, Vaudry H, Fournier A. Biological and structural analysis of truncated analogs of PACAP27. Journal of Molecular Neuroscience : Mn. 36: 260-9. PMID 18473187 DOI: 10.1007/s12031-008-9081-7  0.92
2008 Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A. Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides. 29: 919-32. PMID 18353507 DOI: 10.1016/j.peptides.2008.01.022  0.92
2008 Doan ND, Bourgault S, Létourneau M, Fournier A. Effectiveness of the suzuki-miyaura cross-coupling reaction for solid-phase peptide modification. Journal of Combinatorial Chemistry. 10: 44-51. PMID 18067269 DOI: 10.1021/cc700128b  0.92
2007 Bourgault S, Létourneau M, Fournier A. Development of photolabile caged analogs of endothelin-1. Peptides. 28: 1074-82. PMID 17400333 DOI: 10.1016/j.peptides.2007.02.013  0.92
2006 Ravni A, Bourgault S, Lebon A, Chan P, Galas L, Fournier A, Vaudry H, Gonzalez B, Eiden LE, Vaudry D. The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. Journal of Neurochemistry. 98: 321-9. PMID 16805827 DOI: 10.1111/j.1471-4159.2006.03884.x  0.92
2005 Bourgault S, Létourneau M, Fournier A. Development and pharmacological characterization of "caged" urotensin II analogs. Peptides. 26: 1475-80. PMID 16042988 DOI: 10.1016/j.peptides.2005.03.019  0.92
2003 Brkovic A, Hattenberger A, Kostenis E, Klabunde T, Flohr S, Kurz M, Bourgault S, Fournier A. Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay. The Journal of Pharmacology and Experimental Therapeutics. 306: 1200-9. PMID 12807997 DOI: 10.1124/jpet.103.052415  0.92
Low-probability matches
2000 Thomas ES, Bourgault S. A note on the theoretical existence of invariants: Part I Journal of Difference Equations and Applications. 6: 681-693.  0.08
2000 Bourgault S, Huang YS. The existence of continuous invariants for linear difference equations Journal of Difference Equations and Applications. 6: 739-751.  0.08
2013 Ding W, Young M, Bourgault S, Lee S, Albiani DA, Kirker AW, Forooghian F, Sarunic MV, Merkur AB, Beg MF. Automatic detection of subretinal fluid and sub-retinal pigment epithelium fluid in optical coherence tomography images. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2013: 7388-91. PMID 24111452 DOI: 10.1109/EMBC.2013.6611265  0.01
2016 Miloudi K, Binet F, Wilson A, Cerani A, Oubaha M, Menard C, Henriques S, Mawambo G, Dejda A, Nguyen PT, Rezende FA, Bourgault S, Kennedy TE, Sapieha P. Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy. The Journal of Clinical Investigation. PMID 27400127 DOI: 10.1172/JCI84767  0.01
2015 Bourgault S, Baril C, Vincent A, Héon E, Ali A, MacDonald I, Lueder GT, Colleaux KM, Laliberté I. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series. The British Journal of Ophthalmology. PMID 25926518 DOI: 10.1136/bjophthalmol-2014-305897  0.01
2015 Briand S, Chalifoux E, Tourville E, Bourgault S, Caissie M, Tardif Y, Giasson M, Boivin J, Blanchette C, Cinq-Mars B. Prospective randomized trial: outcomes of SF₆ versus C₃F₈ in macular hole surgery. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 50: 95-100. PMID 25863847 DOI: 10.1016/j.jcjo.2014.12.006  0.01
2015 Bourgault S. A Forgotten Revolutionary Pamphlet: Madame de Genlis on Hospitality Women's Studies. 44: 1130-1155. DOI: 10.1080/00497878.2015.1078214  0.01
2014 Bourgault S. Beyond the saint and the red virgin: Simone weil as feminist theorist of care Frontiers. 35: 1-27. DOI: 10.1353/fro.2014.0019  0.01
2014 Bourgault S. The unbridled tongue: Plato, parrhesia, and philosophy Interpretation (United States). 41: 65-89.  0.01
2013 Bourgault S, Aroichane M, Wittenberg LA, Lavallée A, Ma PE. Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report. Journal of Ophthalmic Inflammation and Infection. 3: 61. PMID 24148192 DOI: 10.1186/1869-5760-3-61  0.01
2013 Bourgault S, Albiani D. Re: Split Ozurdex implant: a caution. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 48: 218-9. PMID 23769786 DOI: 10.1016/j.jcjo.2013.01.025  0.01
2012 Vigneault P, Bourgault S, Kaddar N, Caillier B, Pilote S, Patoine D, Simard C, Drolet B. Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current. European Journal of Pharmacology. 681: 68-74. PMID 22366430 DOI: 10.1016/j.ejphar.2012.02.002  0.01
2012 Bourgault S, Tourville E. Incidence of postoperative hypotony in 25-gauge vitrectomy: oblique versus straight sclerotomies. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 47: 21-3. PMID 22333846 DOI: 10.1016/j.jcjo.2011.12.010  0.01
2012 Bourgault S. Music and pedagogy in the Platonic city Journal of Aesthetic Education. 46: 59-72. DOI: 10.5406/jaesteduc.46.1.0059  0.01
2011 Bourgault S, Bordua-Robert MF, Molgat YM. Recurrent orbital cyst as a late complication of silastic implant for orbital floor fracture repair. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 46: 368-9. PMID 21816260 DOI: 10.1016/j.jcjo.2011.06.017  0.01
2011 Vigneault P, Kaddar N, Bourgault S, Caillier B, Pilote S, Patoine D, Simard C, Drolet B. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much? Journal of Cardiovascular Pharmacology. 57: 690-5. PMID 21394035 DOI: 10.1097/FJC.0b013e318217d941  0.01
2010 Bourgault S, Chmielewska K, Tourville E. Prophylaxis and treatment of irvine-gass syndrome Clinical and Surgical Ophthalmology. 28: 48-55.  0.01
1989 Bourgault S, Le Pape JP, Ranson D. Lislog-C: A first step to generalized expression of constraints in logic programming | Lislog-C: Une première étape vers I'expression généralisée de contraintes en programmation en logique Annales Des TéLéCommunications. 44: 218-228. DOI: 10.1007/BF02995668  0.01
1985 Sansonnet JP, Clere P, Papon E, Bourgault S, Grandjean B. REAL TIME ORIENTED MACHINE FOR A. I. APPLICATIONS . 99-106.  0.01
Hide low-probability matches.